SCHEMBL18615674

SCHEMBL18615674

CNc1ccnc(O[C@H]2CC[C@H](NC(=O)OC(C)(C)C)CC2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK1 P23458 4/20 0.42
▸ JAK2 O60674 3/20 0.42
▸ KDM1A O60341 1/20 0.42
▸ MAOB P27338 1/20 0.42
▸ CKS1B P61024 1/20 0.41
▸ SKP1 P63208 1/20 0.41
▸ SKP2 Q13309 1/20 0.41
▸ CACNB4 O00305 1/20 0.40
▸ CACNA1A O00555 1/20 0.40
▸ CACNA1G O43497 1/20 0.40
▸ CACNG3 O60359 1/20 0.40
▸ CACNA1F O60840 1/20 0.40
▸ CACNA1H O95180 1/20 0.40
▸ CACNB3 P54284 1/20 0.40
▸ CACNA2D1 P54289 1/20 0.40
▸ CACNG7 P62955 1/20 0.40
▸ CACNA1B Q00975 1/20 0.40
▸ CACNA1D Q01668 1/20 0.40
▸ CACNB1 Q02641 1/20 0.40
▸ CACNG1 Q06432 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20357411 0.86 CACNB4 (0.44) JAK1JAK2KDM1AMAOBCKS1B
SCHEMBL18615727 0.86 CACNB4 (0.44) JAK1JAK2KDM1AMAOBCKS1B
SCHEMBL18615454 0.83 KDM1A (0.48) JAK1JAK2KDM1AMAOBCKS1B
SCHEMBL6458275 0.82 JAK1 (0.43) JAK1JAK2KDM1AMAOBCKS1B
SCHEMBL6458263 0.82 JAK1 (0.43) JAK1JAK2KDM1AMAOBCKS1B
SCHEMBL18615603 0.80 CACNB4 (0.43) JAK1JAK2KDM1AMAOBCKS1B
SCHEMBL18615680 0.79 CKS1B (0.46) JAK1JAK2KDM1AMAOBCKS1B
SCHEMBL18615424 0.79 CKS1B (0.47) JAK1JAK2CKS1BSKP1SKP2
SCHEMBL18616061 0.77 CACNB4 (0.44) JAK1JAK2KDM1AMAOBCKS1B
SCHEMBL18615725 0.77 CACNB4 (0.49) JAK1JAK2KDM1AMAOBCKS1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3345893-B1 UREA DERIVATIVE AND USE THEREFOR TORAY INDUSTRIES (JP) 2019-10-30 — — EP disclosed
US-10280145-B2 Urea derivative and use therefor TORAY INDUSTRIES, INC. (JP) 2019-05-07 — — US disclosed
EP-3345893-A1 UREA DERIVATIVE AND USE THEREFOR Toray Industries, Inc. (JP) 2018-07-11 — — EP disclosed
WO-2017038873-A1 UREA DERIVATIVE AND USE THEREFOR 東レ株式会社 2017-03-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10280145-B2 Urea derivative and use therefor UTS2R, DDR1, WEE1 JAK1 226/4885JAK2 1036/4885KDM1A 2748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback